Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia (Q41042591)

26 September 2017

Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia (English)

1 reference

26 September 2017

0 references

7

Kristi Huik

1 reference

26 September 2017

8

Irja Lutsar

1 reference

26 September 2017

1

Radko Avi

1 reference

26 September 2017

2

Merit Pauskar

1 reference

26 September 2017

4

Eveli Kallas

1 reference

26 September 2017

5

Ene-Ly Jõgeda

1 reference

26 September 2017

3

Tõnis Karki

1 reference

26 September 2017

Tõnu Margus

6

1 reference

26 September 2017

20 August 2015

1 reference

Journal of Medical Virology

26 September 2017

1 reference

26 September 2017

88

1 reference

26 September 2017

448-454

1 reference

26 September 2017

3

1 reference

HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations

26 September 2017

1 reference

Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia

21 January 2018

1 reference

Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia

21 January 2018

1 reference

Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.

21 January 2018

1 reference

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort

21 January 2018

1 reference

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.

21 January 2018

1 reference

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

21 January 2018

1 reference

Estonia at the threshold of the fourth decade of the AIDS era in Europe

21 January 2018

1 reference

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

21 January 2018

1 reference

Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal

21 January 2018

1 reference

Are subtype differences important in HIV drug resistance?

21 January 2018

1 reference

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

21 January 2018

1 reference

First report of CRF03_AB recombinant HIV type 1 in injecting drug users in Ukraine

21 January 2018

1 reference

The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa

21 January 2018

1 reference

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial

21 January 2018

1 reference

Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study

21 January 2018

1 reference

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.

21 January 2018

1 reference

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

21 January 2018

1 reference

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

21 January 2018

1 reference

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

21 January 2018

1 reference

HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso

21 January 2018

1 reference

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

21 January 2018

1 reference

Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.24361

1 reference

26 September 2017

1 reference

PubMed ID

26291050